Thank you, Raymond. Good morning everyone, and thank you for joining us on today’s earnings call. Similar to our recent earnings calls, I’ll speak to our second quarter 2022 financial results, and then I’ll pass the call back to Raymond for closing remarks. I would caution this is going to be a bit lengthy. So please bear with me. Revenue in the second quarter of 2022 was $19.3 million compared to revenue of $11.8 million in the second quarter of 2021. This represents a $7.5 million or 63.5% year-over-year increase in comparative quarterly revenue. The increase in our second quarter 2022 revenue was solely attributable to the incremental revenue generated by our extraction division of approximately $10 million, which was partially offset by a decline in our design and build revenue of approximately $1.7 million and cultivation equipment revenue up 759,000. Second quarter 2022 revenue performance was clearly below our expectations. Our second quarter revenue, most notably our extraction related revenue was materially impacted by the current instability in the overall cannabis industry, which resulted in a slowdown in new bookings, as well as customer requested delays in shipping. Both of these factors combined to reduce our anticipated second quarter of 2022 extraction related revenues. Our design and build revenue performance was as expected given the near completion status of several of our TTK projects. Bookings for the second quarter of 2022 were approximately $29 million of which $10.6 million of the bookings amount was related to extraction products. The bookings amounts also include TTK-related bookings, which consists of construction and recurring SaaS and production fees, as well as product bookings, including both cultivation and extraction equipment amounts. We entered the third quarter fiscal 2022 with approximately $779 million in backlog. A significant portion of our reported backlog amount is derived from future TTK-related recurring revenue streams associated with both our SaaS and production success fees, which account for 89% of the total backlog amount. Total gross profit in the associated gross profit margin in the second quarter of 2022 was $1.6 million or roughly 8% of total revenue compared to gross profit of 527,000 or 5% of total revenue in the year ago quarter. Gross profit and gross margin improvements in the comparative year-over-year quarterly periods is driven by the incremental profit and margin contributions from our extraction related product sales. Extraction related revenues achieve a gross margin of approximately 23% in the second quarter of 2022 with cultivation associated revenue including TTK-related revenues, which in the current quarter consisted primarily of design build revenue, contributing a negative gross profit margin of approximately 7%. The primary driver of our lower than anticipated gross profit performance in the second quarter of 2022 is directly related to the quarterly reserves that were provided for slow moving inventory and warranting costs, which totaled 929,000 and 181,000 respectively. In total, these items accounted for a 570 basis point decline in our second quarter gross profit margin. Moving on to operating expenses. Second quarter 2022 general and administrative expenses increased by $15 million or 341% to $19.4 million compared to $4.4 million in the year ago quarter. The comparative increase in G&A expenses in 2022 is largely attributable to an $8.6 million increase in bad debt reserves associated with trade and loans receivable and $800,000 [ph] approval in accordance with tentative agreements to settle one of the company’s legal disputes and increases in G&A expenses related to the incremental G&A assumed in connection with our recent acquisitions. Additional drives of the comparative increase in second quarter 2022 G&A expenses are related to increases in depreciation and amortization expense associated with the intangible assets and one-time charges related to restructuring charges and direct acquisition costs. As it relates to our second quarter 2022 increase in bad debt reserves, approximately $7.1 million of the current quarter reserve is specifically related to Greenstone Holdings. The company established the reserve based upon its review of Greenstone’s financial stability, which could impact future collectibility of the amounts ownedAgrify. Greenstone’s financial instability is in large part associated with the unfavorable conditions within the Colorado cannabis market. The company will continue to monitor the operations of Greenstone in an effort to collect all outstanding receivables, but due to the uncertain nature of Greenstone’s business at this time, the company has made the decision to place a partial reserve against the outstanding receivable amounts. Sales and marketing expenses totaled $2.3 million in the second quarter of 2022, compared to 782,000 in the second quarter of 2021. The comparative increase in second quarter 2022 sales and marketing expenses is also directly related to the company increasing the scale of its business and strategically focusing on investments in sales and marketing activities, such as headcount trade shows and marketing programs, each of these necessary to drive rapid growth. Research and development expense in the second quarter of 2022, totaled $2.4 million compared to $774,000 in the year ago quarter. The increase in research and development expense is essentially reflective of the company’s need to improve and upgrade our Agrify Insight SaaS software as well as the hardware features and functionality of our vertical farming units. Comparative second quarter 2022 increases in R&D expenses are related to current quarter edition of the extraction division R&D teams, third party consulting and payroll and related expenses, as well as additional material advance. We expect to continue to invest in future developments of our VFUs, our Agrify Insights cultivation software and our extraction products. Although we will continue to invest in future R&D activities, we will seek to streamline our R&D processes and to reduce R&D expenses as we move through the rest of fiscal 2022. Operating expenses in the second quarter of 2022 includes a $69.9 million non-cash charge associated with the full impairment of our goodwill and intangible assets. During the three month period ended June 30 2022, the company identified a potential impairment triggering event related to both a sustained decline in our stock price and our associated market capitalization, as well as a second quarter slowdown in the cannabis industry as a whole. In light of those factors, we deemed that it was necessary to perform an interim detailed analysis to support the current carrying value of our long-lived assets, including our goodwill and intangible assets as of June 30, 2022. The results of our interim testing identified as the carrying book value of the cultivation and extraction divisions, equity balances significantly exceeded their calculated fair value of equity by an amount greater than the aggregate value of our goodwill and intangible assets. Accordingly, the company concluded that the entire carrying value of its goodwill and intangible assets should be impaired resulting in the second quarter non-cash impairment charges of $69.9 million. The company as of June 30, 2022 is currently monitoring two separate contingent earn up consideration arrangements associated with the acquisitions of Pure Pressure and Lab Society. Each of the arrangements contains two consecutive 12-month earn-out periods. The potential additional consideration that can be earned under each of the two earn-outs is capped at $1.5 million per year under the Pure Pressure earn-out arrangements and $1.75 million per year under the Lab Society earn-out arrangements. The company made initial estimates for respect to the probability of achievement of the additional consideration to be earned under each prospective earn-out period and recorded it as part of our initial purchase price accounting associated with each acquisition. Operating expenses in the second quarter of 2022 also includes the $907,000 reduction in operating expenses, which is primarily attributable to a change in our fair value estimates of the contingent consideration associated with the currently active Lab Society earn-out. During our periodic review of our fair value estimates we noted that Lab Society’s actual revenue performance related to the first earn-out period, trailed our initially projected estimates. Accordingly, we revised our estimated probabilities of earn-out achievement, which resulted in a reduction of the original estimated earn-out achievement of approximately $1 million. This change in contingent consideration as required by GAAP was recorded as a current period reduction to operating expenses. We will continue to evaluate on a routine periodic basis, future performance against our initial assumptions and estimates on a quarterly basis. Any identified changes to our original assumptions that generate a change to our fair value estimates of probable earn-out achievement will result in either an increase or reduction to our future periodic operating expenses. Lightly touching upon other income expenses, the company is reporting total interest expense of $1.9 million during the second quarter of 2022, compared to interest income of $55,000 in the second quarter of 2021. The primary driver of the increase in interest expense during the second quarter of 2022 is directly related to interest expense associated with our $65 million debt facility combined with the current quarter amortization of the associated debt discount. The interest expense was partially offset by interest income recorded on our TTK-related construction advances. The company is recognizing a $62,000 income tax benefit during the second quarter of 2022, no provision for income taxes was recorded during the second quarter of 2021. The income tax benefit in the three months ended June 30, 2022 was primarily attributable. There’s a goodwill and intangible asset impairment charges recorded during the second quarter of 2022, which resulted in a $62,000 tax benefit related to the reversal of the deferred tax liability on indefinite lived assets. We consolidate the results of operations of less than fully owned entities into our consolidated results of operations, Agrify-Valiant, LLC, a joint venture limited liability company in which we are 60% majority owner and Valiant-America LLC owns the remaining 40%. The reported net income or loss in each of the presented quarterly periods ended June 30, 2022 and 2021 represents the portion of the periodic income or loss attributable to the non-controlling parties. Finally, the net results of the previously discussed changes in revenue, gross margin and operating expenses resulted in a net loss of $93.4 million or $3.51 per diluted share during the second quarter of 2022, compared to a loss of $5.6 million or $0.28 per diluted share in the year ago quarter. Adjusted EBITDA amounted to a loss at $19.4 million during the second quarter of 2022, compared to an adjusted EBITDA loss of $4.5 million in a year ago quarter. Additional information regarding our use of non-GAAP measures, including a reconciliation to the most comparable GAAP measures can be find in the press released, we issued earlier this morning, which is also available on the Investor Relations sections of our website at www.agrify.com. Quickly providing an update on our cash, restricted cash and marketable security balances, we enter the third quarter of 2022 with combined amount of cash, restricted cash and marketable securities of $59.9 million compared to a balance of $56.6 million as of December 31, 2021. As of June 30, 2022, the company is in default of certain financial debt covenants associated with its $65 million senior secured promissory note. Specifically, the company did not achieve its second quarter revenue or adjusted EBITDA targets. We have reached a tentative agreement in principle with our institutional lender to amend our existing credit facility, to modify and eliminate certain financial covenants, which once complete should give us additional flexibility to operate and meet our long-term strategic goals, while also allowing us to responsibly adjust to the challenges currently facing the cannabis industry. We expect that’s a restructuring will involve repayment of the existing note with a combination of cash on hand and through the issuance of the new note, with a reduced principal amount, no amortization of monthly loan repayment and the flexibility of early repayment. We will provide a further update once the agreement has been finalized. That concludes our prepared financial comments. And with that, I will now turn the call back to Raymond for final comments.